posted
BioElectronics Corporation, (Pink Sheets: BIEL - News), today announced that Henry Schein, Inc. (Nasdaq: HSIC - News), the largest provider of healthcare products and services to office-based practitioners in the North American and European markets has agreed to sell and distribute ActiPatch(TM). ActiPatch is a drug-free anti- inflammatory patch. http://biz.yahoo.com/prnews/061009/dcm014.html?.v=65
posted
``But what can often indicate that a company indeed has the 'goods' is third-party validation,'' said Clark. ``One way to gather some understanding is to see if the emerging small cap has deals with larger companies. For example, BioElectronics Corp. (Other OTC:BIEL.PK - News) recently completed a deal with Henry Schein, Inc. (NASDAQ:HSIC - News), the largest provider of healthcare products and services to office-based practitioners in the North American and European markets. If Schein et al has agreed to sell and distribute BioElectronics' ActiPatch drug-free anti-inflammatory patch, the company has significantly separated itself from a legion of zero-revenue, hope-for-the best small caps.''